Fieldpoint Private Securities’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$177K Buy
2,471
+2,227
+913% +$163K 0.05% 270
2022
Q1
$20K Sell
244
-7,451
-97% -$630K ﹤0.01% 858
2021
Q4
$790K Buy
7,695
+1,966
+34% +$189K 0.15% 155
2021
Q3
$501K Buy
5,729
+5,659
+8,084% +$512K 0.11% 201
2021
Q2
$6K Hold
70
﹤0.01% 1187
2021
Q1
$5K Hold
70
﹤0.01% 1222
2020
Q4
$5K Buy
+70
New +$4.36K ﹤0.01% 1144

Other funds holding SYNH

Fieldpoint Private Securities's SYNH Position: Q2 2022 in Review

Fieldpoint Private Securities increased its Syneos Health, Inc. Class A Common Stock (SYNH) stake by 913% in Q2 2022, buying an estimated $163K and bringing the position to 2,471 shares worth $177K. The position accounts for 0.05% of the portfolio, ranked #270.

Fieldpoint Private Securities first reported a position in SYNH in Q4 2020 and has held it in 7 quarters since. The position peaked at $790K in Q4 2021. 361 funds tracked by Wall St. Rank hold SYNH as of Q2 2022.

  • Fieldpoint Private Securities held 2,471 shares of Syneos Health, Inc. Class A Common Stock worth $177K as of Q2 2022.
  • Fieldpoint Private Securities bought 2,227 Syneos Health, Inc. Class A Common Stock shares in Q2 2022, an estimated $163K.
  • Syneos Health, Inc. Class A Common Stock made up 0.05% of Fieldpoint Private Securities's portfolio in Q2 2022, its #270 holding.
  • Fieldpoint Private Securities first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2020 and has held it in 7 quarters since.
  • Fieldpoint Private Securities's Syneos Health, Inc. Class A Common Stock position peaked at $790K in Q4 2021.
  • 361 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.